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intensive care unit
To the Editor: We read the retrospective audit by Mkoko and 
Raine[1] on HIV-positive patients requiring intensive care unit 
(ICU) admission with great interest. Although we acknowledge 
that intensive care is a scarce resource in South Africa (SA), and 
clear guidelines are needed to assist clinicians to allocate resources 
appropriately, we cannot concur with the authors’ conclusion that 
ICU care may have to be withheld from HIV patients with higher 
Acute Physiology and Chronic Health Evaluation ΙΙ (APACHE II) 
scores and the need for organ support such as renal replacement 
therapy and inotropes. The authors also erroneously suggest that ‘this 
is the first study that has determined the outcomes of HIV-positive 
adults admitted to an SA ICU’.
In a prospective study performed by Balkema et al.[2] in the same 
city (Cape Town, SA), during the same period and on a similar 
population, ICU mortality of all HIV patients was 38.9%. ICU 
mortality was associated with an AIDS-defining diagnosis (odds 
ratio 7.97, p=0.003). Non-survivors had higher APACHE II scores 
(25.8 v. 18.6; p=0.001) and lower mean admission CD4+ counts 
(102.5 v. 225.2 cells/µL; p=0.014). Multiple logistical regression 
analysis confirmed the independent predictive value of World Health 
Organization (WHO) stage IV disease (p=0.008), lower mean CD4+ 
counts on admission (p=0.057), and higher APACHE II scores 
(p=0.010) on ICU mortality, and of WHO stage IV disease (p=0.007) 
and higher APACHE II scores (p=0.003) on 30-day mortality. In a 
post hoc analysis, the same investigators retrospectively validated a 
simple six-point scoring system based on the presence of: (i) AIDS; 
(ii) a CD4+ count of <50 cells/µL; (iii) extrapulmonary tuberculosis; 
(iv) Pneumocystis carinii pneumonia; (v) septic shock; and (vi) renal 
dysfunction. More than 80% of patients with a score of ≥3 died, and 
no patient with a score of ≥4 survived.[3]
The ICU mortality in Mkoko and Raine’s study[1] was 25.3% in 
patients with a mean (standard deviation) APACHE II score of 21.6 
(8.4). This would be anticipated, as the predicted mortality with an 
APACHE II score in the range of 20 - 24, regardless of HIV status, 
is up to 40%. Moreover, the APACHE II score was designed as an 
estimate of mortality after 24 hours of ICU care and not as a guide 
to offer or withhold critical care.[4] The need for inotropic support 
is also widely regarded as an independent predictor of mortality 
in HIV-negative ICU patients. The 47% mortality described in the 
study would therefore also be anticipated and may not be indicative 
of mortality specifically attributable to HIV infection in this setting.[5]
We therefore cannot concur with the authors’ interpretation to 
‘withhold’ ICU care in only the HIV population with these general 
critical illness severity indices. In the absence of randomised studies 
or higher levels of evidence, it is still safer to discuss referrals on a 
case-by-case basis and to consider all comorbidities.
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